Similar Search Results

Newton's first law as applied to pharmacies : why entry order matters for generics

Shajarizadeh, Ali; Grootendorst, Paul V.; Hollis, Aidan - In: International journal of the economics of business 22 (2015) 2, pp. 201-217

Persistent link: https://www.econbiz.de/10011405941

Biologics and biosimilars : a primer

Acri, Kristina M. L. - 2020

Persistent link: https://www.econbiz.de/10012249297

How do Brands' "Own Generics" affect pharmaceutical prices?

Hollis, Aidan - In: Review of industrial organization : RIO 27 (2005) 4, pp. 329-350

Persistent link: https://www.econbiz.de/10003275698

The anti-competitive effects of brand-controlled "pseudo-generics" in the Canadian pharmaceutical market

Hollis, Aidan - In: Canadian public policy : a journal for the discussion … 29 (2003) 1, pp. 21-32

Persistent link: https://www.econbiz.de/10001754996

Generic Drug Pricing and Procurement : A Policy for Alberta

Hollis, Aidan - 2017

Canadians pay very high prices for generic drugs compared to international norms. The reason is not ineﬃcient or noncompetitive generic drug companies, but provincial government pricing and insurance policies that are distorting the market. This paper by Professor Aidan Hollis, an expert in...

Persistent link: https://www.econbiz.de/10012946452

Marketing drug products

Olsen, Paul Crand°all - 1964 - Rev. ed

Persistent link: https://www.econbiz.de/10002583490

Canada's Patented Medicines (Notice of Compliance) Regulations : Removing Inefficiencies to Encourage Generic Competition

Porter, Suzanne - 2013

generic competition. Specifically, the regulations should be amended to consolidate multiple proceedings into one cause of …. These features encourage competition without deterring pharmaceutical research and development because only patents that are …

Persistent link: https://www.econbiz.de/10013074086

Generic drugopoly : why non-patented prescription drugs cost more in Canada than in the United States and Europe

Skinner, Brett J. - 2004

Persistent link: https://www.econbiz.de/10002179264

Cross-national price differences for pharmaceuticals : how large, and why?

Danzon, Patricia Munch; Chao, Li-wei - In: Journal of health economics 19 (2000) 2, pp. 159-195

Persistent link: https://www.econbiz.de/10001511446

Preisbildung von Arzneimitteln im internationalen Vergleich

Drabinski, Thomas; Eschweiler, Jan; Schmidt, Ulrich - 2008

Persistent link: https://www.econbiz.de/10003684395

1
2
3
4
5
6
7
8
9
10
Next
Last